BIOATLA INC's ticker is BCAB and the CUSIP is 09077B104. A total of 54 filers reported holding BIOATLA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $50,143 | -93.6% | 18,710 | -80.2% | 0.00% | -100.0% |
| Q4 2022 | $778,371 | +746.1% | 94,348 | +689.2% | 0.00% | +300.0% |
| Q3 2022 | $92,000 | +109.1% | 11,955 | -22.2% | 0.00% | – |
| Q2 2022 | $44,000 | -51.1% | 15,368 | -14.3% | 0.00% | -100.0% |
| Q1 2022 | $90,000 | -86.9% | 17,936 | -48.8% | 0.00% | -80.0% |
| Q4 2021 | $687,000 | +172.6% | 35,019 | +373.2% | 0.01% | +25.0% |
| Q4 2020 | $252,000 | – | 7,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,624,076 | $9,712,524 | 1.45% |
| Soleus Capital Management, L.P. | 4,321,197 | $11,580,808 | 1.20% |
| Affinity Asset Advisors, LLC | 325,000 | $871,000 | 0.29% |
| SECTORAL ASSET MANAGEMENT INC | 543,009 | $1,455,264 | 0.28% |
| Cormorant Asset Management, LP | 1,181,115 | $3,165 | 0.21% |
| Orbimed Advisors | 3,861,000 | $10,347,480 | 0.20% |
| Vivo Capital, LLC | 637,181 | $1,707,645 | 0.12% |
| Boxer Capital, LLC | 686,347 | $1,839 | 0.09% |
| Atom Investors LP | 55,476 | $148,676 | 0.08% |
| MYDA Advisors LLC | 55,000 | $147,400 | 0.06% |